The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

China Cord Blood Corp

NYSE: CO
Last

(U.S.) $4.42

Today's change+0.02 +0.45%
Updated December 26 4:02 PM EST. Delayed by at least 15 minutes.
 

China Cord Blood Corp

NYSE: CO
Last

(U.S.) $4.42

Today's change+0.02 +0.45%
Updated December 26 4:02 PM EST. Delayed by at least 15 minutes.

China Cord Blood Corp up (U.S.)$0.02

China Cord Blood Corp closed up Friday by (U.S.)$0.02 or 0.45% to (U.S.)$4.42. Over the last five days, shares have gained 3.03% and 10.22% year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $4.38
  • Previous close(U.S.) $4.40
  • High(U.S.) $4.46
  • Low(U.S.) $4.38
  • Bid / Ask-- / --
  • YTD % change+10.22%
  • Volume8,152
  • Average volume (10-day)48,502
  • Average volume (1-month)77,120
  • Average volume (3-month)68,574
  • 52-week range(U.S.) $3.70 to (U.S.) $5.70
  • Beta1.07
  • Trailing P/E16.66×
  • P/E 1 year forward18.95×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.27
Updated December 26 4:02 PM EST. Delayed by at least 15 minutes.
S&P TSX0.10%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013Sep 30, 201309/30/2013
Revenue153152151142
Total other revenue--------
Total revenue153152151142
Gross profit124125124114
Total cost of revenue30272727
Total operating expense93888585
Selling / general / administrative61585556
Research & development2322
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income60646656
Interest income (expense), net non-operating-25-17-22-16
Gain (loss) on sale of assets--------
Other--------
Income before tax42534945
Income after tax30403525
Income tax, total12131420
Net income30403525
Total adjustments to net income---15----
Net income before extra. items30403525
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items30243525
Inc. avail. to common incl. extra. items30243525
Diluted net income30243525
Dilution adjustment00----
Diluted weighted average shares73498475
Diluted EPS excluding extraordinary itemsvalue per share0.410.500.410.33
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.410.500.410.33